Northland Biotech Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Private

  • Employees
  • 193

Employees

  • Latest Deal Type
  • IPO

Northland Biotech General Information

Description

Beijing Northland Biotech Co Ltd is engaged in technology transfer, technical services, production and sales of ophthalmic drugs, contract manufacturing, and contract research and development. The company's independently developed biopharmaceutical, NL003, has completed Phase III clinical trials this year.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • A406, Zhongguancun Biomedical Park
  • No. 5 Shangdi Kaixing Road, Haidian District
  • Beijing
  • China
+86 010
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Vertical(s)
Corporate Office
  • A406, Zhongguancun Biomedical Park
  • No. 5 Shangdi Kaixing Road, Haidian District
  • Beijing
  • China
+86 010

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Northland Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. IPO 15-Nov-2021 Completed Generating Revenue
4. Later Stage VC 09-Jan-2019 Completed Generating Revenue
3. Later Stage VC 24-Mar-2016 Completed Generating Revenue
2. Later Stage VC 02-Jul-2014 $11.6M $11.6M Completed Generating Revenue
1. IPO 18-Feb-2009 Completed Profitable
To view Northland Biotech’s complete valuation and funding history, request access »

Northland Biotech Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Ordinary
Ordinary 7,230,000 $1.45 $1.45 1x $1.45 6.45%
To view Northland Biotech’s complete cap table history, request access »

Northland Biotech Patents

Northland Biotech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3909974-A1 Human hepatocyte growth factor mutant and uses thereof Pending 07-Jan-2019
EP-3909974-A4 Human hepatocyte growth factor mutant and uses thereof Pending 07-Jan-2019
US-12264186-B2 Human hepatocyte growth factor mutant and uses thereof Active 07-Jan-2019
US-20220064242-A1 Human hepatocyte growth factor mutant and uses thereof Active 07-Jan-2019
WO-2020143515-A1 Human hepatocyte growth factor mutant and uses thereof Inactive 07-Jan-2019 C07K14/4753
To view Northland Biotech’s complete patent history, request access »

Northland Biotech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Northland Biotech Investments (2)

Northland Biotech’s most recent deal was a Joint Venture with Joint Venture (Epi Biotech / Northland Biotech). The deal was made on 14-Apr-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Joint Venture (Epi Biotech / Northland Biotech) 14-Apr-2025 Joint Venture Clinics/Outpatient Services
Huonland 03-Aug-2012 Joint Venture Pharmaceuticals
To view Northland Biotech’s complete investments history, request access »

Northland Biotech ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Pharmaceuticals

Subindustry

Rank

Percentile

To view Northland Biotech’s complete esg history, request access »

Northland Biotech FAQs

  • When was Northland Biotech founded?

    Northland Biotech was founded in 2004.

  • Where is Northland Biotech headquartered?

    Northland Biotech is headquartered in Beijing, China.

  • What is the size of Northland Biotech?

    Northland Biotech has 193 total employees.

  • What industry is Northland Biotech in?

    Northland Biotech’s primary industry is Drug Discovery.

  • Is Northland Biotech a private or public company?

    Northland Biotech is a Private company.

  • What is Northland Biotech’s current revenue?

    The current revenue for Northland Biotech is .

  • How much funding has Northland Biotech raised over time?

    Northland Biotech has raised $26.3M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process